The annual burden of illness for GI bleeding in the U.S. is $7.5 billion.1 GI bleeding should be suspected in patients who present with anemia, melena, or hematochezia. Every year, in the U.S., 4.4 million patients present with suspected GI bleeding, but up to 10% remain undiagnosed following EGD/colonoscopy.2,3
Radiofrequency ablation is a minimally-invasive procedure aimed to treat bleeding by providing coagulation in conditions such as gastric antral vascular ectasia (GAVE) and radiation proctitis (RP).
Peery A, Dellon E, Lund J, Crockett S, Mcgowan C, Bulsiewicz W, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology. 2012;143:1179-87.
Zhu A, Kaneshiro M, Kaunitz J. Evaluation and treatment of iron deficiency anemia: a gastroenterological perspective. Digestive Disease Sciences. 2010;55:548-559.
Internal Data–Internal Market Model. July, 2015. Data on file.
Image does not represent all components of the system